232 related articles for article (PubMed ID: 36246978)
21. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
[TBL] [Abstract][Full Text] [Related]
22. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
23. High miR-31-5p expression promotes colon adenocarcinoma progression by targeting TNS1.
Mi B; Li Q; Li T; Liu G; Sai J
Aging (Albany NY); 2020 Apr; 12(8):7480-7490. PubMed ID: 32315285
[TBL] [Abstract][Full Text] [Related]
24. Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer.
Liu K; Lai M; Wang S; Zheng K; Xie S; Wang X
Biomed Res Int; 2020; 2020():6107865. PubMed ID: 32337262
[TBL] [Abstract][Full Text] [Related]
25. LINC01123 facilitates proliferation, invasion and chemoresistance of colon cancer cells.
Ye S; Sun B; Wu W; Yu C; Tian T; Lian Z; Liang Q; Zhou Y
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32700743
[TBL] [Abstract][Full Text] [Related]
26. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
27. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
28. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
[TBL] [Abstract][Full Text] [Related]
30. Exosomal lncRNA PVT1/VEGFA Axis Promotes Colon Cancer Metastasis and Stemness by Downregulation of Tumor Suppressor miR-152-3p.
Lai SW; Chen MY; Bamodu OA; Hsieh MS; Huang TY; Yeh CT; Lee WH; Cherng YG
Oxid Med Cell Longev; 2021; 2021():9959807. PubMed ID: 34336125
[TBL] [Abstract][Full Text] [Related]
31. Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10.
Li W; Ma JA; Sheng X; Xiao C
World J Surg Oncol; 2021 Nov; 19(1):329. PubMed ID: 34794429
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.
Liu L; Bi N; Wu L; Ding X; Men Y; Zhou W; Li L; Zhang W; Shi S; Song Y; Wang L
Mol Cancer; 2017 Feb; 16(1):50. PubMed ID: 28241836
[TBL] [Abstract][Full Text] [Related]
33. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma.
Wang JY; Jiang JB; Li Y; Wang YL; Dai Y
Biomed Pharmacother; 2017 Sep; 93():1047-1054. PubMed ID: 28738498
[TBL] [Abstract][Full Text] [Related]
35. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
Meng C; Zhang Y; Jiang D; Wang J
World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
[TBL] [Abstract][Full Text] [Related]
36. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer.
Dong X; Zhang Y; Sun Y; Nan Q; Li M; Ma L; Zhang L; Luo J; Qi Y; Miao Y
BMC Med Genomics; 2023 Jun; 16(1):148. PubMed ID: 37370088
[TBL] [Abstract][Full Text] [Related]
38. ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma.
Yuan X; He Y; Wang W
Sci Rep; 2023 Oct; 13(1):16932. PubMed ID: 37805556
[TBL] [Abstract][Full Text] [Related]
39. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
[TBL] [Abstract][Full Text] [Related]
40. Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma.
Zhang L; Cao H; Gu G; Hou D; You Y; Li X; Chen Y; Jiao G
Front Oncol; 2022; 12():884559. PubMed ID: 35651811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
